跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RTC 560mg Tablet - NPRA Drug Approval Details
Approvals
/
NPRA
/
RTC 560mg Tablet
Approved
STANDARD
RTC 560mg Tablet
DARULAMAN MANUFACTURING SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
73b3b397b8ff419d
Company
DARULAMAN MANUFACTURING SDN. BHD.
Type
Standard
Approval Details
Approval Id
73b3b397b8ff419d
Drug Approval Npra Name
RTC 560mg Tablet
Product Name
RTC 560mg Tablet
Registration Number
MAL16080053T
Holder Company Name
DARULAMAN MANUFACTURING SDN. BHD.
Holder Address
LOT 59, 60, 61 & 62 TAMAN INDUSTRI KEDA NAPOH 06000 JITRA MALAYSIA
Holder Phone
04-9161767
Manufacturer Company Name
DARULAMAN MANUFACTURING SDN. BHD.
Manufacturer Address
LOT 59, 60, 61 & 62 TAMAN INDUSTRI KEDA NAPOH 06000 JITRA MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL16080053T
Version
1751614237
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
73b3b397b8ff419d
Type
Standard
Source
Official Source
Back to NPRA Approvals